TechyBird Acquisition registered to offer 6 million units at $10 each. A unit consists of one share and a right to receive one-fifth of a share.
The underwriters have a 45-day option to buy an additional 900,000 shares.
The new SPAC plans to focus on the biotechnology and pharmaceutical sectors, including potential targets in China.
Xu Zhenchun has been director, CEO and chairman of the SPAC since its inception in August. Xu specializes in high-tech project investment analysis, strategic planning in mergers and acquisitions. He is executive director of Everpower International Holdings Ltd. in the United States. He has promoted the industrialization of major projects such as new energy vehicles and artificial intelligence, as well as cross-border investment and mergers and acquisitions.
TechyBird intends to apply for a Nasdaq listing under the symbol TKBDU. Read more.
